TITLE

Long-term use of angiotensin-converting enzyme inhibitors to modify endothelial dysfunction: a review of clinical investigations

AUTHOR(S)
Mancini, G.B. John
PUB. DATE
April 2000
SOURCE
Clinical & Investigative Medicine;Apr2000, Vol. 23 Issue 2, p144
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Abstract Objectives: Endothelial dysfunction can be modified by angiotensin-converting enzyme (ACE) inhibitors. The purpose of this paper is to review clinical studies assessing the effect of long-term, oral ACE inhibition on endothelial dysfunction in specific disease syndromes and to identify areas requiring further research. Data sources: A computer search of the entire MEDLINE database and Current Contents complemented by detailed analysis of references in the papers identified. Study selection: Analysis of patients treated on a long-term basis with orally administered ACE inhibitors to modify endothelial function Data synthesis: Studies were identified of patients with hypertension, diabetes, congestive heart failure, coronary artery disease, dyslipidemias and immunoglobulin A nephropathy (IgAN). These studies used diverse endothelium-mediated end-points, which included dilatory responses in conduit or resistance vessels, measures of coagulant and fibrinolytic factors, soluble adhesion molecules, endothelin-1, systemic and glomerular barrier functions and renal blood flow. Few trials enrolled large numbers of patients or used randomized, double-blind, placebo-controlled designs. However, consistent and positive effects were noted in patients with coronary artery disease, dyslipidemia or IgAN. In hypertensive patients, conduit artery and renal endothelium-mediated responses could be improved earlier and more easily than resistance vessel function, which appears to require prolonged therapy before improvement is seen. Highly disparate results were found in patients with congestive heart failure or diabetes. Conclusions: ACE inhibitors appear to improve endothelial dysfunction in patients with coronary artery disease, dyslipidemia, hypertension and IgAN. Conflicting evidence exists in studies of patients with congestive heart failure and diabetes. Further trials are required to clarify and define the prevalence of endothelial dysfunction and the predictors of ...
ACCESSION #
3182506

 

Related Articles

  • Two ACEs and a heart. Bernstein, Kenneth E. // Nature;6/20/2002, Vol. 417 Issue 6891, p799 

    Comments on an article by M.A. Crackower and colleagues on the cardiac function of angiotensin-converting enzyme (ACE) 2. Physiology of the peptide angiotensin II; Importance of angiotensin II; Discovery of ACE2.

  • Progression of Diabetic Retinopathy Limited by ACE Inhibitor.  // Kidney;Jan/Feb99, Vol. 8 Issue 1, p18 

    Focuses on an investigation into the effect of the angiotensin-converting enzyme (ACE) inhibitor lisinopril on retinopathy in type 1 diabetes. Finding that lisinopril decreased retinopathy progression in normotensive type 1 diabetic patients.

  • Support is substantial for routinely prescribing ACE inhibitors for CHF.  // Modern Medicine;Aug95, Vol. 63 Issue 8, p45 

    Presents an abstract of the study titled `Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure', by R. Garg and S. Yusus, published in the May 10, 1995 issue of `Journal of the American Medical Association.'

  • ACE inhibitor slows diabetes-related renal disease.  // Geriatrics;Jul94, Vol. 49 Issue 7, p53 

    Presents the summary of findings from the study entitled `Effect of Captopril on Progression to Clinical Proteinuria in Patients with Insulin-Dependent Diabetes Mellitus and Microalbuminuria' conducted by G. Viberti and others, published in the 1994 issue of the `Journal of the American Medical...

  • Male-female differences in fertility and blood pressure in ACE-deficient mice. Krege, John H.; John, Simon W. M. // Nature;5/11/1995, Vol. 375 Issue 6527, p146 

    Investigates the role of angiotensin-converting enzyme (ACE) gene in blood pressure control and reproduction using mice generated to carry an insertional mutation that inactivates both forms of ACE. Methods of the study; Discussion of results.

  • Sporty types. Coghlan, Andy // New Scientist;05/23/98, Vol. 158 Issue 2135, p7 

    Reports on research being done by a team led by Hugh Montgomery of the University College London, to monitor the effects of two common variants of the gene that makes angio-tensin-converting enzyme (ACE). How the enzyme helps regulate blood pressure; How sporting champions have higher levels of...

  • Combined treatment with angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARB): 'Beating a dead horse' or meaningful mechanism-guided therapy? Petroianu, G. A. // Indian Journal of Pharmacology;Oct2006, Vol. 38 Issue 5, p372 

    The author reflects on the pros and cons of combining the angiotensin-converting enzyme (ACE) inhibitors with the angiotensin-receptor blockers. It has been stressed that while the existence of ACE inhibition is valid, the arguments are still strong. It was found out that the clinical effects of...

  • Angiotensin-converting Enzyme Activity by Canine Pulmonary Microvascular and Central Pulmonary Artery Endothelial Cells Exposed to Hypoxia. Tamaru, N.; Watanabe, K.; Yoshida, M.; Reitz-Vick, D.M.; Townsend, L.; Glover N., J. // Lung;2000, Vol. 178 Issue 4, p249 

    To compare the amount of angiotensin-converting enzyme (ACE) activ-ity in pulmonary artery endothelial cells from different sites and to examine the effect of severe hypoxia (less than 1% of O 2 in 5% CO 2 and 95% N 2 ) on the ACE activity expressed by these cells, endothelial cells were...

  • Angiotensin I-Converting Enzyme: A Pathogenetic Role in Diabetic Renal Damage? Lely, A. Titia; Luik, Peter T.; Navis, Gerjan // Current Diabetes Reviews;2007, Vol. 3 Issue 1, p41 

    The renin-angiotensin aldosterone system (RAAS) is well-established to be involved in diabetic nephropathy. Several abnormalities in the RAAS have been described in diabetes mellitus, including an abnormal aldosterone to renin ratio, elevated angiotensin I-converting enzyme (ACE) levels, and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics